By Admin 
This statement of Hassabis is not just theory. His company Deepmind has already worked on projects such as Alphafold, which has been highly accurately produced by millions of protein structures. This is the same technique from which the work used for years in the development of medicines can now be done in a few months.
Gave to CBS Interview He said, “Our aim is to have radical abundance, that is, medical resources and treatment, so that healthcare does not remain on expensive treatment or long waiting list.” He also admitted that all this would not be easy, but if the speed and accuracy of AI remains under control, then medical science can completely change in the next decade.
In a conversation with Time magazine, Hassabis also added that Deepmind and Google’s parent company Alphabet, no longer AI wants to limit AI to the tech industry, but its real target is core sectors like health and science.
However, he also talked clear about AI’s risk. Hassabis says that if AI was misused, or left without regulations, this system can also prove to be harmful. Therefore, along with technology, a moral and regulated framework is also necessary. This vision of Deepmind shows that in the coming years, the role of AI in the medical and pharma industry can be not just supportive, but can be a centerl.